chrisvoncsefalvay/vaers-outcomes huggingface dataset:
my whole left back torso broke out.; Not 2 nd booster for Me; This case was reported by a consumer and described the occurrence of skin breakout in a patient who received Herpes zoster (Shingles vaccine) for prophylaxis.   Co-suspect products included Herpes zoster (Shingles vaccine) for prophylaxis.   The patient's past medical history included shingles (had 3 little scars). Previously administered products included Steroid.   On an unknown date, the patient received the 1st dose of Shingles vaccine and the 2nd dose of Shingles vaccine. On an unknown date, unknown after receiving Shingles vaccine and not applicable after receiving Shingles vaccine, the patient experienced skin breakout and incomplete course of vaccination. On an unknown date, the outcome of the skin breakout and incomplete course of vaccination were unknown.   It was unknown if the reporter considered the skin breakout to be related to Shingles vaccine.  Additional details were provided as follows: This case was reported by patient himself/herself. The age at vaccination was not applicable for this report for 2nd dose. The patient received Shingles vaccine and whole left back, torso broke out. Till the time of reporting, the patient did not receive 2nd dose, which led to incomplete course of vaccination.
Fever and headache and tiredness started about 14 hours after injection in upper left arm/shoulder and lasted about  48 hours.  The area of the injection became red and hot and expanded to the size of a baseball and enlarged to a lump about 1/4 inch above  flat skin level. Then extreme stomach and diarrhea mid-day on 1/20/2021 for the next 12 hours. While most symptoms have subsided, the injection area remains a lump the size of a baseball as of 1/22/2021.
12 year old received vaccine; This spontaneous case was reported by an other health care professional and describes the occurrence of PRODUCT ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE (12 year old received vaccine) in a 12-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 002M21A) for COVID-19 vaccination.     Previously administered products included for Product used for unknown indication: Pfizer and Pfizer. Past adverse reactions to the above products included No adverse event with Pfizer and Pfizer.    On 31-May-2022, the patient received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) .25 milliliter. On 31-May-2022, the patient experienced PRODUCT ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE (12 year old received vaccine). At the time of the report, PRODUCT ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE (12 year old received vaccine) outcome was unknown.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   No concomitant product use was provided.  This patient has not reported any symptoms. No additional doses, medications, or treatments have been administered at this time.
On 01/19/2021 at 03/30 am I experienced an  dizzy state and fell to the bathroom floor. My wife called 911 and I was taken by ambulance to the hospital. At the hospital  , they performed an MRI, CATSCAN and a heart ultrasound. I was diognosed with a Istemic Stroke.
Pain at injection site; should is warm; should is inflamed; hurts to move his shoulder upward; This case was reported by a consumer via call center representative and described the occurrence of injection site pain in a 59-year-old male patient who received Herpes zoster (Shingrix) for prophylaxis.   On 25th March 2022, the patient received the 1st dose of Shingrix. On an unknown date, less than 3 weeks after receiving Shingrix, the patient experienced injection site pain, skin warm, inflammation and shoulder pain. The patient was treated with naproxen (Aleve). On an unknown date, the outcome of the injection site pain, skin warm, inflammation and shoulder pain were not recovered/not resolved.   It was unknown if the reporter considered the injection site pain, skin warm, inflammation and shoulder pain to be related to Shingrix.     Additional Information: GSK Receipt Date: 11-APR-2022 Reporter's comment: The reporter was the patient. The patient received first dose of Shingrix in his left upper arm, since then he experienced pain at the injection site, his left shoulder was warm and inflamed and it hurt to move his shoulder upward. The patient has used ice and heat as well as Aleve to alleviate the symptoms. The reporter consented to follow up with HCP (health care professional) (pharmacy).
Overnight body aches, sore muscles & joints, chills, low grade fever, back pain
HPV shot put my neighbors daughter in a coma; This case was reported by a consumer via interactive digital media and described the occurrence of coma in a female patient who received HPV 16-18 (HPV vaccine) for prophylaxis.   Concurrent medical conditions included autism.   On an unknown date, the patient received HPV vaccine. On an unknown date, unknown after receiving HPV vaccine, the patient experienced coma (serious criteria GSK medically significant). On an unknown date, the outcome of the coma was unknown.   It was unknown if the reporter considered the coma to be related to HPV vaccine.  Additional information was provided as follows: The age at vaccination was not reported. The patient received a dose of HPV vaccine and was in coma after the vaccination. The reporter mentioned that, the babies with autism were given HPV shot when they had no way to stop the eugenics programs. Poison pushing establishments have profitted while people have actually suffered. The reporter also mentioned that, there was no accountability on how the doctors were administrating the shots even after reading the pamphlets but again the FDA had ruled that those shots were safe. The case is linked with the case number- US2021AMR028881, reported by the same reporter.; Sender's Comments:  US-GLAXOSMITHKLINE-US2021AMR028881:Same reporter
Pt recv vax on 10/20/98; on same day pt exp sharp pains in left ear & nasal drip, tired, not eating, weight loss, bronchitis & cough; dx=possible polyarteritis nodosa & Churg Strauss syndrome; tx=Prednisone
p/vax pt exp flu-like symptoms; T102; and sweating; no treatment given
This spontaneous report was received from a pharmacist, and refers to a 21 year old female patient with hypersensitivity to amoxicillin. The patient had no concomitant medications or pertinent medical history. On 15-OCT-1997, the patient was vaccinated with the first dose of M-M-R II, she received the second dose of this vaccine on 17-JUL-2002, for prophylaxis (dose, anatomical site, route of administration, lot number and expiration date were not reported). Sterile diluent (MERCK STERILE DILUENT) was used for reconstitution, however, it was not specified which of the doses were reconstituted with it. On 20-JUL-2018, the patient had titers drawn, which showed she was positive for immunity of rubella but she was negative for immunity of measles and mumps. The patient sought medical attention, however, she did not receive any treatment for the events. At the time of the report the patient had not recovered from the events. The causality assessment between the events and the therapy with M-M-R II was not reported.
not feeling well; her husband experienced chills; This spontaneous case was reported by a consumer and describes the occurrence of MALAISE (not feeling well) and CHILLS (her husband experienced chills) in a 75-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 031M20A and 013L20H) for COVID-19 prophylaxis.     Previously administered products included for Product used for unknown indication: Influenza (given within 1 month prior to Moderna COVID-19 vaccine). Past adverse reactions to the above products included No adverse event with Influenza. Concurrent medical conditions included Hypertension, Alcoholism, Kidney failure, Allergy to animal (Cats) and Stomach function disorder. Concomitant products included AMLODIPINE for Hypertension, OMEPRAZOLE for Stomach function disorder.   On 22-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 19-Feb-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 22-Jan-2021, the patient experienced MALAISE (not feeling well) and CHILLS (her husband experienced chills). On 23-Jan-2021, MALAISE (not feeling well) and CHILLS (her husband experienced chills) had resolved.            Patient did not seek any medical care and experienced a similar event in the past. No treatment medications were reported.   This case was linked to MOD-2022-591122, MOD-2022-591120 (Patient Link).
Patient felt pain at injection site, heaviness, couldn't sleep on first day. On the second day, injection site start getting swollen, hematoma started to appear close to injection site, then spread to lower arm. When patient came back to the pharmacy today, which is 2 weeks after the vaccination,  hematoma still presents all over the arm.  Pain is still present, but improving.  Patient has been taking Tylenol to help with pain.  Patient was instructed to notify MD.
History of Present Illness: Patient is a(n) 67 Y female with a PMH of asthma, HTN, HLD, GERD who arrived to the ED via rescue squad with complaints of sudden onset of squeezing chest pain/tightness that radiated to the back, associated dyspnea, lightheadedness and dizziness that began around 6:30PM.  Pt reports she was feeling well prior to the episode and she had her COVID 19 vaccine at 4:30PM and had tolerated the vaccine well.  She does report that she had atrial fibrillation before, about 5 years ago and she underwent a cardiac work up.  She denied palpitations, fever, chills, body aches, nausea, or vomiting.  She does have a non productive cough.  Her BP normally runs 130/80's at home and is controlled w amlodipine.  She was given SL nitro and aspirin in the ambulance.  EKG showed atrial fibrillation with RVR, HR 150's.  Reason for admission: Atrial fibrillation with rapid ventricular response (*) Atrial fibrillation with RVR (*)    She was admitted for further evaluation and monitoring.  Troponin level noted to be 0.79 and EKG with ST-T wave changes, cardiology was consulted and patient underwent cardiac cath who revealed no significant CAD hyperdynamic LVEF 70 %.  She developed a small hematoma post catheterization which has resolved.  Cardizem was switched to metoprolol and both BP and HR are improved and controlled with losartan.  Pt without any adverse effects to losartan, no s/s angioedema.  Afib with an abrupt onset and abrupt return to normal sinus rhythm.  She complained of calf pain, US dopplers were obtained and were negative for DVT.  Her D Dimer was also normal.    Pt discharge to home in stable condition.
Headache, Fever, NauseaVomiting, injection site pain for 4 days Narrative:  slight darkening of all nail beds half moon shape at bottom of nails. This last 3 weeks and has resolved. 2 weeks after dose episode of fever of 102.4. Resolved no issues.
a friend had the same reaction but it only lasted 3 or 4 days; Based on the current case data, this case has been classified as invalid. This spontaneous case was reported by a consumer and describes the occurrence of TYPE IV HYPERSENSITIVITY REACTION (a friend had the same reaction but it only lasted 3 or 4 days) in a patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced TYPE IV HYPERSENSITIVITY REACTION (a friend had the same reaction but it only lasted 3 or 4 days). At the time of the report, TYPE IV HYPERSENSITIVITY REACTION (a friend had the same reaction but it only lasted 3 or 4 days) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.
p/vax pt c/o fever 101, chills joint aches & low back pain;pt denied SOB, rash or erythema @ site, chest pain or dysuria;refused to come into town;instructed to have APAP & call if s/s inc;
Left Deltoid red, Swollen and warm to touch. DTap #5 and MMR #2 administered 7/5/06.
Information has been received from a registered nurse concerning a 26 year old overweight female with no allergies to yeast or steroids who on 8/16/05 was vaccinated IM in her right arm with a 1.0ml first dose of RECOMBIVAX HB  (lot # 647974/0181R). Post-vaccination (between approximately 8/17/05 and 8/20/05) the patient developed a lump in the right arm at the injection site, which tripled in size by 8/21/05. The patient's arm was also red and hot to touch. On 8/21/05, the patient was seen at a walk in clinic and was prescribed cefdinir, 300mg BID for 7 days for abscess of right arm. The patient told the nurse that she feels better now, only knot size lump remained. There was no product quality complaint involved. The patient's adverse experiences were considered to be other important medical events. Additional information has been requested.
Ths is in follow-up to report (s) previously submitted on 2/14/2007. Information has been received from a Certified Nurse Midwife concerning a 20 year old female who is "prone to panic attacks" who on 29-JAN-2007 at 11:15 am was vaccinated IM with the first dose of Gardasil (yeast) (Lot # not provided). At 7:30 pm that same evening the patient experienced a panic attack with severe nausea, vomiting and difficulty breathing and went to the emergency room. The patient was not admitted to the hospital. At the time of this report it was unknown if the patient had recovered from the events. Additional information has been requested. Information has been received from A Certified Nurse Midwife concerning a 20 year old female with an anxiety disorder who is "prone to panic attacks" who on 29-JAN-2007 at 11:15 am was vaccinated intramuscularly with the first dose of GARDASIL (Lot # 654702/0011U). At 7:10 pm that same evening the patient experienced a panic attack with severe nausea, vomiting and difficulty breathing and went to the emergency room. The patient was not admitted to the hospital. At the time of this report it was unknown if the patient had recovered from the events. Follow up information received stated that the patient presented to the emergency room at 10:00 pm on 29-JAN-2007 with complaints of dizziness, nausea, malaise and parethesias. The patient was treated with PHENERGAN 50 mg and discharged home from the emergency room. Subsequently the patient recovered from the events. Additional information has been requested.
Breakthrough case admission after 3 vaccines MOderna 4/24/21 Lot# 043B21A;  Moderna 5/22/21 Lot# 041C21A;  Moderna 7/24/22 Lot# 014B22A
This spontaneous report as received from a physician refers to a 24 year old patient. The reporter reported the unspecified patient "was administered the first dose in the GARDASIL vaccination series in 2008 and was administered the second dose of GARDASIL on an unspecified date. The third dose of GARDASIL would be administered at some point in 2013". No adverse effect reported. Additional information has been requested.
4APR94 grandmother called to report granddaughter had a fever & noted jerking movements when holding; also noted jerky movement when holding pt; mom also noted jerky movements Sunday noc; temp not taken;
pt recvd vax & devel a rash on hands; No further details were provided;
MD Notes: History of Present Illness 77-year-old female with past medical history hypertension, hyperlipidemia presenting with weakness.  Patient reports about 4 days of generalized weakness associated with mild shortness of breath.  Also with decreased appetite.  No chest pain.  No fevers.  No abdominal pain, nausea, vomiting.  Patient reports to be fully vaccinated Covid.
Sore arm; Slight headache; This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (Sore arm) and HEADACHE (Slight headache) in a 70-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 032M20A) for COVID-19 vaccination.     The patient's past medical history included No adverse event.    On 04-Mar-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 05-Mar-2021, the patient experienced PAIN IN EXTREMITY (Sore arm) and HEADACHE (Slight headache). At the time of the report, PAIN IN EXTREMITY (Sore arm) and HEADACHE (Slight headache) had resolved.            No treatment information was provided. No relevant concomitant medications reported.
SUSPECTED CLINICAL VACCINATION FAILURE; SUSPECTED COVID-19 INFECTION; This spontaneous report received from a patient concerned a 55 year old female. The patient's height, and weight were not reported. The patient's concurrent conditions included: sinusitis, high blood pressure, prediabetes, allergy to almonds, abstains alcohol, and non smoker, and other pre-existing medical conditions included: The patient did not have any drug abuse/illicit drug use. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, and batch number: 1805025, expiry: UNKNOWN) dose was not reported, 1 total, administered on 13-MAR-2021 to left arm for prophylactic vaccination. No concomitant medications were reported.  On 04-JUN-2021, the patient tested positive to covid-19 (suspected clinical vaccination failure and suspected covid-19 infection) after receiving the vaccine. She stated that she walked in to a walk-in clinic thinking it as sinus and received some sinus treatment then the test came back as positive to Covid-19. Her symptoms were stuffy nose and cough. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient recovered from suspected covid-19 infection, and the outcome of suspected clinical vaccination failure was not reported. This report was serious (Other Medically Important Condition). This report was associated with product quality complaint: 90000191510.; Sender's Comments: V0: 20210860158-COVID-19 VACCINE AD26.COV2.S - Suspected clinical vaccination failure . This event is considered not related. The event has a compatible/suggestive temporal relationship, is unlabeled, and has unknown scientific plausibility. There are other factors more likely to be associated with the event than the drug. Specifically: SPECIAL SITUATIONS
Received the Moderna vaccine 30 April 2021 from Pharmacy. On 8 May 2021 woke up form sleeping with the smell of smoke. This is very annoying and give me headaches. A constant smell of smoke everyday.
Fever of 103.2 followed by diffuse maculopapular rash starting on the trunk progressing to the hands and feet.
Information has been received from a physician concerning a 2 month old female who was vaccinated PO with a dose of ROTATEQ. Subsequently the patient experienced acid reflux. It was unknown whether medical attention was sought. The patient was no treated with any medicine. Subsequently, the acid reflux went away and the patient was fully recovered. Additional information has been requested. This is one of several reports from the same source.
Nausea, fever/feeling of warmth over whole body, pain with movement of arm, warmth at injection site, swelling and redness at injection site (left arm at deltoid site).
Left eye feels aching; Vision interference; This case was reported by a consumer via call center representative and described the occurrence of eye pain in a adult patient who received Herpes zoster (Shingles vaccine) for prophylaxis.   On an unknown date, the patient received Shingles vaccine at an unknown dose. On an unknown date, less than 2 weeks after receiving Shingles vaccine, the patient experienced eye pain and abnormal vision. On an unknown date, the outcome of the eye pain and abnormal vision were unknown.   It was unknown if the reporter considered the eye pain and abnormal vision to be related to Shingles vaccine.  Additional details were provided as follows: The age at vaccination was not reported. The patient stated that they had the shingles vaccine and their left eye felt aching vision interference. No further details captured, the patient was getting out of car and states they were calling in. Requested follow up, but contact did not give a response to question.
On intake form stated that date of birth was 6/22/2004, father stated patient 16 years of age or older but had no ID to verify that. When trying to resolve billing issues later in the day, insurance has date of birth of 6/22/2005. Father informed that since ID was not provided to confirm patient age the second dose will not be completed
Early in the evening I began to feel abnormally tired.  After going to bed, I woke up at midnight freezing with the same type of body chills I had during COVID.  At 4:00 a.m. I woke up drenched in sweat from head to toe.  I got up to change my cloths and felt dizzy.  I then began vomiting.  I returned to bed and basically slept all day.  Through out the day I had body aches and pretty severe aches in my joints and hips.  I did take some tylenol around 1:00 p.m.  I began to feel less achy around 4:00 p.m.  Today is the second day and I feel better but still tired and somewhat achy.  I just took additional tylenol.
Erythema, warmth, itching covering 80 percent of upper arm, pain, unable to lift arm fully due to discomfort.
Fever, chills, arm soreness, muscle aches, and fatigue lasting three (3) days.
Painful R Deltoid x 2 days, followed by chills, fever, diarrhea evening of day 3.   Malaise day4.  Tight feeling (semi headache) from then on (probably related to Increased BP) culminating in BP of 202/102 and TIA day 10.  Taken  to ED.  CT scan performed-no bleeding. Physicians assumed TIA caused heightened BP.  Not so.  BP decreasing graduallly, today, day 13 now around 135/80 (still elevated for me).  semi-H/A resoluved.
Total body hives for 3 months treated with topical and oral steroids and oral antihistamines. Severe nasal allergy symptoms treated with antihistamines. X 3 months. New onset herpes simplex type1 treated with oral Valtrex. Severe PACs treated with Atenolol and Xanax symptoms remain.
Neck, shoulder and upper back pain began after vaccination, and has persisted. Treatment: Physical therapy and postural training. Intermittent NSAIDs with no other benefit than temporary. Pain is now chronic.
Pt had high pitch, unconsolable cry about 4 hours after administration of vaccines. Mom tried nursing, warm compress, and TYLENOL. Child is soothed temporarily, but resumes crying. Comfort measures discussed.
Felt like vaccine was injected into subacromial space left arm/shoulder. Began having shoulder soreness and pain, progressing as afternoon and evening progressed 1/4/21. Had difficulty sleeping with frequent interruptions due to shoulder pain on 1/4/21 and 1/5/21. Unable to lift arm to shoulder height due to pain, difficulty and pain to reach faucet, get dressed, shower, overall functional use LUE with modifications required. Treated with over-the-counter ibuprofen 2-3x/day with temporary decrease in pain intensity. Iced shoulder twice. Symptoms began to improve during night 1/6/21 with improved sleeping tolerance. Steady decrease in symptoms 1/7/21 and 1/8/21 with pain with certain movements shoulder only.
2-12-08 began breaking out-red blotches-itching, tightness- (L) ear- preceded by tingling, burning, odd sensation (L) ear _> (L) temple, cheek, jaw, shoulder. Rx of Valacyclovir 1000mg po TID x 7 days.
On March 31, 2023, I had a headache, cough, congestion, brain fog. I took a home COVID-19 test that came back positive. I called my doctor but was unable to get in touch with my doctor, so I went the urgent care to get treatment. I was given a prescription of PAXLOVID. I started taking the medication immediately and was feeling good. Ten days after being in quarantine I tested positive again. Six days later I went to the emergency room with rapid heart palpitations of 156 beats per. They hooked me up to an EKG, took bloodwork, CT scan of my abdominal area, chest x-ray. All tests came back normal. I have a follow up visit with my cardiologist for a stress test as I am still experiencing heart palpitations.